Powers A - Search Results

1

The biological activities of simian virus 40 large-T antigen and its possible oncogenic effects in humans.

Matker CM, Rizzo P, Pass HI, Di Resta I, Powers A, Mutti L, Kast WM, Carbone M. Matker CM, et al. Among authors: powers a. Monaldi Arch Chest Dis. 1998 Apr;53(2):193-7. Monaldi Arch Chest Dis. 1998. PMID: 9689808 Review.

2

The role of environmental carcinogens, viruses and genetic predisposition in the pathogenesis of mesothelioma.

Powers A, Carbone M. Powers A, et al. Cancer Biol Ther. 2002 Jul-Aug;1(4):348-53. Cancer Biol Ther. 2002. PMID: 12432244 Review.

3

The detection of simian virus 40 in human tumors by polymerase chain reaction.

Rizzo P, Di Resta I, Powers A, Matker CM, Zhang A, Mutti L, Kast WM, Pass H, Carbone M. Rizzo P, et al. Among authors: powers a. Monaldi Arch Chest Dis. 1998 Apr;53(2):202-10. Monaldi Arch Chest Dis. 1998. PMID: 9689810 Review.

4

New molecular and epidemiological issues in mesothelioma: role of SV40.

Carbone M, Fisher S, Powers A, Pass HI, Rizzo P. Carbone M, et al. Among authors: powers a. J Cell Physiol. 1999 Aug;180(2):167-72. doi: 10.1002/(SICI)1097-4652(199908)180:2<167::AID-JCP4>3.0.CO;2-Q. J Cell Physiol. 1999. PMID: 10395286 Review.

5

Simian virus 40 is present in most United States human mesotheliomas, but it is rarely present in non-Hodgkin's lymphoma.

Rizzo P, Carbone M, Fisher SG, Matker C, Swinnen LJ, Powers A, Di Resta I, Alkan S, Pass HI, Fisher RI. Rizzo P, et al. Among authors: powers a. Chest. 1999 Dec;116(6 Suppl):470S-473S. doi: 10.1378/chest.116.suppl_3.470s. Chest. 1999. PMID: 10619511

6

Human mesothelial cells are unusually susceptible to simian virus 40-mediated transformation and asbestos cocarcinogenicity.

Bocchetta M, Di Resta I, Powers A, Fresco R, Tosolini A, Testa JR, Pass HI, Rizzo P, Carbone M. Bocchetta M, et al. Among authors: powers a. Proc Natl Acad Sci U S A. 2000 Aug 29;97(18):10214-9. doi: 10.1073/pnas.170207097. Proc Natl Acad Sci U S A. 2000. PMID: 10954737 Free PMC article.

7

SV40 and the pathogenesis of mesothelioma.

Rizzo P, Bocchetta M, Powers A, Foddis R, Stekala E, Pass HI, Carbone M. Rizzo P, et al. Among authors: powers a. Semin Cancer Biol. 2001 Feb;11(1):63-71. doi: 10.1006/scbi.2000.0347. Semin Cancer Biol. 2001. PMID: 11243900 Review.

8

Unique strains of SV40 in commercial poliovaccines from 1955 not readily identifiable with current testing for SV40 infection.

Rizzo P, Di Resta I, Powers A, Ratner H, Carbone M. Rizzo P, et al. Among authors: powers a. Cancer Res. 1999 Dec 15;59(24):6103-8. Cancer Res. 1999. PMID: 10626798

9

No evidence of HIV and SIV sequences in two separate lots of polio vaccines used in the first U.S. polio vaccine campaign.

Rizzo P, Matker C, Powers A, Setlak P, Heeney JL, Carbone M. Rizzo P, et al. Among authors: powers a. Virology. 2001 Aug 15;287(1):13-7. doi: 10.1006/viro.2001.0955. Virology. 2001. PMID: 11504537 Free article.

10

Molecular analyses, morphology and immunohistochemistry together differentiate pleural synovial sarcomas from mesotheliomas: clinical implications.

Carbone M, Rizzo P, Powers A, Bocchetta M, Fresco R, Krausz T. Carbone M, et al. Among authors: powers a. Anticancer Res. 2002 Nov-Dec;22(6B):3443-8. Anticancer Res. 2002. PMID: 12552937

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

993 results

Search Page

Filters